Therapeutic potential of BMSC-conditioned medium in an in vitro model of renal fibrosis using the RPTEC/TERT1 cell line

키워드

참고문헌 (36)

1. Romagnani P, "Chronic kidney disease", Nat Rev Dis Primers, 3, pp.17088~ (2017)
2. Ju SH, "Clinical features and molecular mechanism of muscle wasting in end stage renal disease", BMB Rep, 56, pp.426~438 (2023)
3. Kim KP, "Cell-matrix interactions in renal fibrosis", Kidney Dial, 2, pp.607~624 (2022)
4. Wang C, "An update on renal fibrosis : from mechanisms to therapeutic strategies with a focus on extracellular vesicles", Kidney Res Clin Pract, 42, pp.174~187 (2023)
5. Nogueira A, "Pathophysiological mechanisms of renal fibrosis : a review of animal models and therapeutic strategies", In Vivo, 31, pp.1~22 (2017)
6. Schnaper HW, "The tubulointerstitial pathophysiology of progressive kidney disease", Adv Chronic Kidney Dis, 24, pp.107~116 (2017)
7. Zhang JQ, "Cellular senescence of renal tubular epithelial cells in renal fibrosis", Front Endocrinol, 14, pp.1085605~ (2023)
8. Huang Y, "Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications", Int J Mol Sci, 23, pp.10023~ (2022)
9. Wang Y, "Plasticity of mesenchymal stem cells in immunomodulation : pathological and therapeutic implications", Nat Immunol, 15, pp.1009~1016 (2014)
10. Zhuang Q, "Mesenchymal stem cells in renal fibrosis : the flame of cytotherapy", Stem Cells International, 2019, pp.8387350~ (2019)
11. Liu B, "Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-tomesenchymal transition via the TLR4", NF-kappaB signaling pathway in vivo and in vitro, 2018, pp.9, 7~
12. Semedo P, "Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model", Stem Cells, 27, pp.3063~3073 (2009)
13. Qin L, "Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin", Acta Pharmacol Sin, 44, pp.268~287 (2023)
14. Wu HJ, "Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis", PLoS One, 9, pp.e90883~ (2014)
15. Zhou Y, "Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro", Stem Cell Res Ther, 4, pp.34~ (2013)
16. Zhang J, "Quantitative evaluation of real-time shear-wave elastography under deep learning in children with chronic kidney disease", Sci Program, 2022, pp.6051695~ (2022)
17. Guimaraes CF, "The stiffness of living tissues and its implications for tissue engineering", Nat Rev Mater, 5, pp.351~370 (2020)
18. Samir AE, "Shear wave elastography in chronic kidney disease : a pilot experience in native kidneys", BMC Nephrology, 16, pp.119~ (2015)
19. Ishihara S, "Stiffnessmodulation of collagen gels by genipin-crosslinking for cell culture", Gels, 9, pp.148~ (2023)
20. Ishihara S, "Substrate stiffness regulates temporary NF-κB activation via actomyosin contractions", Exp Cell Res, 319, pp.2916~2927 (2013)
21. Desai SS, "Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4alpha", Hepatology, 64, pp.261~275 (2016)
22. Goffin JM, "Focal adhesion size controls tension-dependent recruitment of α-smooth muscle actin to stress fibers", J Cell Biol, 172, pp.259~268 (2006)
23. Sacchi M, "Bioengineered 3D models to recapitulate tissue fibrosis", Trends Biotechnol, 38, pp.623~636 (2020)
24. Davidson MD, "Engineered biomaterial platforms to study fibrosis", Adv Healthc Mater, 9, pp.1901682~ (2020)
25. Secker PF, "Functional transepithelial transport measurements to detect nephrotoxicity in vitro using the RPTEC", TERT1 cell line, 2019, pp.93, 1965~1978
26. Wang XJ, "Molecular and functional profiling of apical versus basolateral small extracellular vesicles derived from primary human proximal tubular epithelial cells under inflammatory conditions", J Extracell Vesicles, 10, pp.e12064~ (2021)
27. Kim DA, "Effects of long-term tubular HIF-2alpha overexpression on progressive renal fibrosis in a chronic kidney disease model", BMB Rep, 56, pp.196~201 (2023)
28. Fintha A, "Therapeutic targeting of fibrotic epithelial-mesenchymal transition-an outstanding challenge", Front Pharmacol, 10, pp.388~ (2019)
29. Yan H, "Defining therapeutic targets for renal fibrosis : exploiting the biology of pathogenesis", Biomed Pharmacother, 143, pp.112115~ (2021)
30. Gluba-Sagr A, "The role of miRNA in renal fibrosis leading to chronic kidney disease", Biomedicines, 11, pp.2358~ (2023)
31. Ichii O, "MicroRNAs associated with the development of kidney diseases in humans and animals", J Toxicol Pathol, 31, pp.23~34 (2018)
32. Zhao H, "microRNAs in chronic kidney disease", Clinica Chimica Acta, 491, pp.59~65 (2019)
33. Glowacki F, "Increased circulating miR-21 levels are associated with kidney fibrosis", PLoS One, 8, pp.e58014~ (2013)
34. McClelland AD, "miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7", Clin Sci(Lond), 129, pp.1237~1249 (2015)
35. Bai L, "MiR-27b-3p inhibits the progression of renal fibrosis via suppressing STAT1", Hum Cell, 34, pp.383~393 (2021)
36. Gregory PA, "The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1", Nat Cell Biol, 10, pp.593~601 (2008)

관련 논문AI추천